These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36552769)

  • 1. Intensive Care Unit Acquired Weakness Is Associated with Rapid Changes to Skeletal Muscle Proteostasis.
    Ozdemir M; Bomkamp MP; Hyatt HW; Smuder AJ; Powers SK
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle-specific differences in expression and phosphorylation of the Janus kinase 2/Signal Transducer and Activator of Transcription 3 following long-term mechanical ventilation and immobilization in rats.
    Salah H; Fury W; Gromada J; Bai Y; Tchkonia T; Kirkland JL; Larsson L
    Acta Physiol (Oxf); 2018 Mar; 222(3):. PubMed ID: 29032602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox Control of Proteolysis During Inactivity-Induced Skeletal Muscle Atrophy.
    Powers SK; Ozdemir M; Hyatt H
    Antioxid Redox Signal; 2020 Sep; 33(8):559-569. PubMed ID: 31941357
    [No Abstract]   [Full Text] [Related]  

  • 4. RNA-sequencing reveals altered skeletal muscle contraction, E3 ligases, autophagy, apoptosis, and chaperone expression in patients with critical illness myopathy.
    Llano-Diez M; Fury W; Okamoto H; Bai Y; Gromada J; Larsson L
    Skelet Muscle; 2019 Apr; 9(1):9. PubMed ID: 30992050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive care unit-acquired weakness: unanswered questions and targets for future research.
    Piva S; Fagoni N; Latronico N
    F1000Res; 2019; 8():. PubMed ID: 31069055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep and Intensive Care Unit-Acquired Weakness in Critically Ill Older Adults.
    Elías MN; Munro CL; Liang Z; Calero K; Ji M
    Dimens Crit Care Nurs; 2019; 38(1):20-28. PubMed ID: 30499789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anabolic Strategies for ICU-Acquired Weakness. What Can We Learn from Bodybuilders?
    Tarnawski J; Czub M; Dymecki M; Sunil M; Folwarski M
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms.
    Ochala J; Gustafson AM; Diez ML; Renaud G; Li M; Aare S; Qaisar R; Banduseela VC; Hedström Y; Tang X; Dworkin B; Ford GC; Nair KS; Perera S; Gautel M; Larsson L
    J Physiol; 2011 Apr; 589(Pt 8):2007-26. PubMed ID: 21320889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis.
    Fazzini B; Märkl T; Costas C; Blobner M; Schaller SJ; Prowle J; Puthucheary Z; Wackerhage H
    Crit Care; 2023 Jan; 27(1):2. PubMed ID: 36597123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechano-signalling pathways in an experimental intensive critical illness myopathy model.
    Corpeno Kalamgi R; Salah H; Gastaldello S; Martinez-Redondo V; Ruas JL; Fury W; Bai Y; Gromada J; Sartori R; Guttridge DC; Sandri M; Larsson L
    J Physiol; 2016 Aug; 594(15):4371-88. PubMed ID: 26990577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive vascular occlusion stimulus (RVOS) versus standard care to prevent muscle wasting in critically ill patients (ROSProx):a study protocol for a pilot randomised controlled trial.
    Chhetri I; Hunt JEA; Mendis JR; Patterson SD; Puthucheary ZA; Montgomery HE; Creagh-Brown BC
    Trials; 2019 Jul; 20(1):456. PubMed ID: 31340849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICU-acquired weakness.
    Vanhorebeek I; Latronico N; Van den Berghe G
    Intensive Care Med; 2020 Apr; 46(4):637-653. PubMed ID: 32076765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Masseter muscle myofibrillar protein synthesis and degradation in an experimental critical illness myopathy model.
    Akkad H; Corpeno R; Larsson L
    PLoS One; 2014; 9(4):e92622. PubMed ID: 24705179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms Underlying Intensive Care Unit-Acquired Weakness and Sarcopenia.
    Kanova M; Kohout P
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Titin Is a Novel Biomarker for Muscle Atrophy in Nonsurgical Critically Ill Patients: A Two-Center, Prospective Observational Study.
    Nakanishi N; Tsutsumi R; Hara K; Takashima T; Nakataki E; Itagaki T; Matsuo M; Oto J; Sakaue H
    Crit Care Med; 2020 Sep; 48(9):1327-1333. PubMed ID: 32706557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical illness-associated diaphragm weakness.
    Dres M; Goligher EC; Heunks LMA; Brochard LJ
    Intensive Care Med; 2017 Oct; 43(10):1441-1452. PubMed ID: 28917004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of corticosteroids in the development of limb muscle weakness in a porcine intensive care unit model.
    Aare S; Radell P; Eriksson LI; Akkad H; Chen YW; Hoffman EP; Larsson L
    Physiol Genomics; 2013 Apr; 45(8):312-20. PubMed ID: 23429211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant.
    Talbert EE; Smuder AJ; Min K; Kwon OS; Szeto HH; Powers SK
    J Appl Physiol (1985); 2013 Aug; 115(4):529-38. PubMed ID: 23766499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intensive Care Unit-Acquired Weakness].
    Siao SF; Yen YH; Yu YF; Zong SL; Chen CC
    Hu Li Za Zhi; 2020 Jun; 67(3):6-13. PubMed ID: 32495324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.